The official journal title is the Blood Res since 2013. It continues the Korean Journal of Hematology (1996–2012, p-ISSN 1738-7949, e-ISSN 2092-9129). It is the official journal of The Korean Society of Hematology.

The Blood Res has on online submission and peer review system at https://www.bloodresearch.or.kr/thesis/

All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

All of the submitted manuscripts undergo intensive peer review by at least two independent reviewers and are selected based on the importance of the topic, originality of the work, quality of the content, and the compliance to the journal's format. On the basis of the comments of the reviewers, the Associate Editor primarily determines whether the article is acceptable or not. A decision is made as "acceptance", "minor revision", "major revision" or "rejection". The author can check the status and the results of the review on the online system. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewers' opinion. Failure to resubmit the revised manuscript within 90 days is regarded as a withdrawal. Based on the opinion of the Associate Editor, the Editor-in-Chief will make a final decision on the approval for publication of the finally revised manuscripts and can request any further corrections or revisions if necessary. Statistical editing may be done if the data need professional statistical review by a statistician. The final revised manuscript should be submitted within 1 week of the request. If a manuscript is accepted for publication, the author will receive an acceptance letter by e-mail. The order of publication is the duty of the Editor-in-Chief. Any errors discovered in the articles after publication should be notified to the Editorial Office and be inserted in Erratum.

This journal is owned by the publisher, Korean Society of Hematology (https://www.hematology.or.kr/eng/main/main.html).

The governing body is the journal's editorial board. The full names and affiliations of the journal’s editors and members of journal management team are displayed on the About (Editorial Board) tab of journal homepage, and the contact information for the Editor and editorial office is on the About (Contact Us) tab.

Copyright to all published materials is owned by Korean Society of Hematology. All authors should agree to the copyright transfer during the submission process.

Blood Res is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of Blood Res in other journals, books or media for scholarly, educational purposes, the process of permission request to the publisher of Blood Res is not necessary. All contents of the journal are available immediately upon publication without embargo period.

Blood Res uses the Open Access publishing model in which all published articles are freely available to readers directly from the Journal's website. There is no article processing charge, also known as a publication fee including submission fee, for accepted articles.

The editorial board of Blood Res have carefully examined all submitted manuscripts whether these are abided by the ethical guidelines of the ICMJE and COPE. The published articles have involved the statements of conflict of interest, institutional review board, informed consent, and human/animal rights.

When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the COPE (http://publicationethics.org/resources/flowcharts). The editorial board of Blood Res will discuss the suspected cases and reach a decision. Blood Res will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

Blood Res follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr).

Our publication ethics are displayed on the Editorial Policy (Publication Ethics) tab of journal homepage.

Blood Res is published 4 times (March 31, June 30, September 30, and December 31) a year.

Blood Res is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

Full text of Blood Res has been archived in National Library of Korea (http://www.nl.go.kr). According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher's version/PDF. Blood Res provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in National Library of Korea.

Revenue sources of journal are from the support of publisher (Korean Society of Hematology) and advertising rates.

Blood Res accepts advertisements. The policy of advertising is displayed on the Policy (Advertising Policy) tab of journal homepage.

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.